CymaBay Therapeutics, Inc. announced the appointment of Dr. Éric Lefebvre to its Board of Directors. Dr. Lefebvre is serving as Chief Medical Officer of Pliant Therapeutics, Inc., a biopharmaceutical company, where he has served as such since May 2018. Prior to joining Pliant, Dr. Lefebvre served as the Vice President of Research and Development at Allergan plc, a global pharmaceutical company, from November 2016 until April 2018.
CymaBay Therapeutics, Inc.
Equities
CBAY
US23257D1037
Biotechnology & Medical Research
1st Jan change | Capi. | |
---|---|---|
+15.36% | 121B | |
+18.27% | 112B | |
+4.43% | 22.57B | |
-18.23% | 20.82B | |
-14.89% | 16.3B | |
-16.61% | 16.19B | |
-43.53% | 16.17B | |
+2.15% | 13.17B | |
+24.25% | 11.11B |